Autres langues Getinge AB

Actions

Temps réel estimé Cboe Europe Autres places de cotation 11:54:06 29/04/2024			Varia. 5j.	Varia. 1 janv.
238,1 ^SEK	+1,28%		+2,77%	+6,02%

24/04	GETINGE : Q1 24 : Les investisseurs regardent au-delà de la baisse du chiffre d'affaires
22/04	Getinge AB (publ) déclare un dividende, payable le 29 avril 2024	CI

GETINGE : Q1 24: Investors look beyond the top-line miss	24/04
Nordic Stocks Closed Up Monday; Getinge Series B Climbed Highest	22/04
Resolutions at Getinge's Annual General Meeting 22 April 2024	22/04
Getinge AB Declares A Dividend, Payable on 29 April 2024	22/04
Getinge : Presentation Q1 2024	22/04
Medical gear maker Getinge's Q1 core profit beats expectations	22/04
Getinge Interim Report January-March 2024: Higher sales, strong cash flow and new products creating more customer value	22/04
Getinge AB Reports Earnings Results for the First Quarter Ended March 31, 2024	22/04
Getinge’s Covered Stent System Gets EU Medical Device Regulation Certification	11/04
Getinge invites fund managers, analysts, and media to Q1 Report 2024 conference call	08/04
GETINGE : EPS cut (2023: +3.1%, 2024: -10.5%)	04/04
Getinge : Fluobeam LX Launch in Amman, Jordan	01/04
Getinge : extends the bioreactor portfolio with larger single-use systems	28/03
Lighting the Way to Excellence: Getinge's new innovative products launch	27/03
Getinge : Corporate Governance Report 2023 (including Auditor’s Report)	27/03
Getinge publishes 2023 annual report	27/03
Getinge : and CellRev launch platform with potential to transform allogeneic cell therapy manufacturing	25/03
NOTICE OF ANNUAL GENERAL MEETING IN GETINGE AB (PUBL)	15/03
Getinge AB Announces Barbro Fridén Declines Re-Election from the Board	15/03
Getinge AB Proposes Dividend, Payable on April 29, 2024	15/03

Aucun résultat pour cette recherche

GETINGE : Q1 24 : Les investisseurs regardent au-delà de la baisse du chiffre d'affaires

Le 24 avril 2024 à 08:06

Getinge AB : partenaire des chirurgiens et des cliniciens